We tested the binding of the G3D2 soluble antibody by staining K562 cells transduced to overexpress TACI as well as a panel of human multiple myeloma cell lines (MM1S, RPMI-8226, and U266) and evaluated binding by flow cytometry (Fig. 1c). This evidence concerns the gene TNFRSF13B and plasma cell myeloma.